Overview

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the impact of escitalopram on quality of life and social functionality in patients with major depressive disorder with anxiety symptom.

Phase:

Phase 4

Details

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Treatments:

Citalopram
Dexetimide